Single-Use Device Reprocessor Adven Enters FDA Consent Decree
This article was originally published in The Gray Sheet
Executive Summary
A consent decree between Adven Medical and FDA signals the agency's readiness to pursue enforcement action against reprocessors violating quality systems regulations